Clindamycin Phosphate in 0.9% Sodium Chloride Injection recall

CGMP Deviations

Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.

Quantity: N/A

Check whether you have the product (match the lot numbers, dates or codes in the official notice). Stop using it, and return it or throw it away as the notice says.

Company

Baxter Healthcare Corporation, Deerfield, IL

Date

Wednesday, September 9

Severity

Class II
the product could cause temporary or reversible health problems.

Where sold

Nationwide
US Nationwide; Puerto Rico; and Chile.

Status

Ongoing

Recall number

D-0816-2026

Source

U.S. Food and Drug Administration